 Home > Active Ingredient News > Antitumor Therapy > ESMO Open: Health-related quality of life helps predict the short-term mortality risk of patients with ovarian cancer!

ESMO Open: Health-related quality of life helps predict the short-term mortality risk of patients with ovarian cancer!

 Last Update: 2021-04-17
 Source: Internet
 Author: User

Tags

supplement health

mai animal health

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recurrent ovarian cancer (rOC) is an incurable disease with a poor prognosis.

Ovarian cancer

Health-related quality of life (HRQoL) is a self-reported prognostic indicator of patients, usually used to measure the effect of treatment, and is an independent predictor of patient survival.

974 patients from 3 clinical studies from NOGGO were included in the exploratory analysis cohort, and 1,235 patients from multiple clinical studies from AGO were included in the validation cohort.

Short-term mortality of patients in different risk groups

The receiver operating characteristics analysis shows that the area under the curve in the exploratory analysis and verification analysis of Model 1 are 0.

The area under the curve in the exploratory analysis and validation analysis of Model 1 were 0.

Death risk prediction performance

In summary, the risk scoring method developed in this study that incorporates HRQoL can well distinguish patients with recurrent ovarian cancer with low, medium, and high short-term mortality.

The risk scoring method developed in this study that incorporates HRQoL can well distinguish patients with recurrent ovarian cancer with low, medium, and high short-term mortality.

Original source:

Armbrust R,Richter R,Woopen H et al.

org/10.
1016/j.
esmoop.
2021.
100081" target="_blank" rel="noopener">Impact of health-related quality of life (HRQoL) on short-term mortality in patients with recurrent ovarian, fallopian or peritoneal carcinoma (the NOGGO-AGO QoL Prognosis-Score-Study): results of a meta-analysis in 2209 patients

in this leave a message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.